Anuh Pharma Secures European Regulatory Approval for Veterinary Antibiotic Sulfadimethoxine
Key Insights
Anuh Pharma (search) received a Certificate of Suitability from the European Directorate for the Quality of Medicines & HealthCare (search) for sulfadimethoxine, expanding access to regulated markets.
Sulfadimethoxine is a bacteriostatic antibiotic that inhibits bacterial folic acid synthesis by acting as a competitive inhibitor against para-aminobenzoic acid.
The drug is widely approved for veterinary use in dogs, cats, small mammals, reptiles, and livestock, serving as the most commonly prescribed treatment for coccidiosis (search) in dogs.
Anuh Pharma (search), a BSE-NSE listed bulk drug manufacturer, has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (search) (EDQM (search)) for sulfadimethoxine, marking a significant regulatory milestone that will expand the company's access to regulated markets.
The approval reinforces Anuh Pharma (search)'s commitment to delivering high-quality Active Pharmaceutical Ingredients that align with global regulatory requirements. According to the company, the CEP for sulfadimethoxine will enable expanded access to regulated markets and support customers with enhanced reliability, compliance, and supply security.
Mechanism of Action and Clinical Applications
Sulfadimethoxine is a bacteriostatic antibiotic that works by inhibiting bacteria from synthesizing folic acid, an essential compound for bacterial growth and survival. The drug achieves this therapeutic effect by acting as a competitive inhibitor against para-aminobenzoic acid (PABA), disrupting the bacterial metabolic pathway.
The antibiotic demonstrates broad veterinary applications and is widely approved for use in dogs, cats, small mammals, reptiles, and livestock. Sulfadimethoxine holds particular clinical significance as the most commonly prescribed medication for the treatment of coccidiosis (search), an intestinal parasite infection, in dogs.
Therapeutic Scope
Beyond its primary indication for coccidiosis (search), sulfadimethoxine shows efficacy against various bacterial infections affecting multiple organ systems. The drug is utilized for treating respiratory, urinary tract, enteric, and soft tissue bacterial infections across different animal species.
Company Profile
Anuh Pharma (search) positions itself as one of the largest manufacturers of macrolides and anti-TB products in India. The company maintains a significant presence in the pharmaceutical manufacturing sector as a major player in anti-bacterials, anti-malarial, and corticosteroids production.
The EDQM (search) certification represents a crucial step in the company's strategy to meet stringent global regulatory standards and expand its international market presence in the veterinary pharmaceutical sector.